Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


The hetero ring contains at least eight members including nitrogen and carbon

Subclass of:

540 - Organic compounds -- part of the class 532-570 series

540000000 - ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1)

540001000 - HETEROCYCLIC CARBON COMPOUNDS CONTAINING A HETERO RING HAVING CHALCOGEN (I.E., OXYGEN, SULFUR, SELENIUM OR TELLURIUM) OR NITROGEN AS THE ONLY RING HETERO ATOMS

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
540451000 Chalcogen double bonded directly to a ring carbon of the hetero ring which is adjacent to the ring nitrogen (e.g., laurolactam, etc.) 127
540470000 The hetero ring contains plural nitrogens 31
540465000 Heavy metal or aluminum containing 29
540467000 The hetero ring contains chalcogen 18
540476000 Polycyclo ring system which contains the hetero ring as one of the cyclos 15
540466000 Spiro 7
540480000 Additional hetero ring attached directly or indirectly to the hetero ring by nonionic bonding 4
200901769803-Substituted-6-Aryl Pyridines - 3-substituted-6-aryl pyridines of Formula I are provided:07-09-2009
20110077395INHIBITORS OF 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I - Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure:03-31-2011
20120083602BENZAMIDES AND RELATED INHIBITORS OF FACTOR XA - Novel benzamide compounds including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivatives having activity against mammalian factor Xa are described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating coagulation disorders.04-05-2012
20120116072NOVEL BENZENESULFONAMIDE COMPOUNDS, METHOD FOR SYNTHESIZING SAME, AND USE THEREOF IN MEDICINE AS WELL AS IN COSMETICS - Benzenesulfonamide compounds having a structure of the following general formula (I) are described. Also described, are methods for synthesizing the compounds, and to the use thereof in pharmaceutical compositions for human or veterinary medicine and in cosmetic compositions.05-10-2012
540483000 Plural nitrogens attached indirectly to the hetero ring by acyclic nonionic bonding 1
20100204467LANTHANIDE (III) ION COMPLEXING COMPOUNDS, LUMINESCENT LANTHANIDE (III) ION COMPLEXES AND USE THEREOF AS FLUORESCENT LABELS - Lanthanide (III) ion complexing compound comprising:08-12-2010
540482000 Chalcogen or nitrogen attached directly to the hetero ring by nonionic bonding 1
20130005961NOVEL COMPOUND AND PROCESS FOR PRODUCING AMIDE COMPOUND THEREWITH - The present invention provides novel cyclododecanone-O-azacyclotridecen-2-yloxime and cyclododecanone-O-azacyclotridecen-2-yloxime hydrochloride. The invention also provides a process for producing an amide compound wherein cyclododecanone-O-azacyclotridecen-2-yloxime, hydrogen chloride and/or Lewis acid or cyclododecanone-O-azacyclotridecen-2-yloxime hydrochloride are used as a rearrangement catalyst and/or a reaction starting material in a reaction step.01-03-2013
Entries
DocumentTitleDate
20090023916TETRAZINE-BASED BIO-ORTHOGONAL COUPLING REAGENTS AND METHODS - Coupling reactions, suitable for use in organic or aqueous media, are performed by contacting a 1,2,4,5-tetrazine with a dienophile. The dienophile may be covalently bonded to a protein, and the coupling reaction may be performed in biological media such as those containing cells or cell lysates. The reactions may be performed in the presence of primary amines, thiols, acetylenes, azides, phosphines, and products of Staudinger and/or Sharpless-Huisgen reactions Novel 3-substituted cyclopropene compounds and trans-cyclooctenes are exemplary dienophiles for these reactions.01-22-2009
20110275797N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF - An N-acyl anthranilic acid derivative represented by general formula (1) or a salt thereof is useful for prevention or treatment of diseases associated with excessive production of collagen. (In the formula, R11-10-2011
20120214988PHOSPHORAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL - Disclosed is a method for highly efficiently obtaining an optically active alcohol from a carbonyl compound highly enantioselectively. Also disclosed is a ligand used in such a method. Specifically, an optically active alcohol is obtained by reacting a carbonyl compound and an organozinc compound by using a ligand (L) shown below.08-23-2012
20140088303PHOSPHORAMIDE COMPOUND, METHOD FOR PRODUCING THE SAME, LIGAND, COMPLEX, CATALYST AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL - Disclosed is a method for highly efficiently obtaining an optically active alcohol from a carbonyl compound highly enantioselectively. Also disclosed is a ligand used in such a method. Specifically, an optically active alcohol is obtained by reacting a carbonyl compound and an organozinc compound by using a ligand (L) shown below.03-27-2014

Patent applications in all subclasses The hetero ring contains at least eight members including nitrogen and carbon

Website © 2025 Advameg, Inc.